Díaz-Gay, Marcos https://orcid.org/0000-0003-0658-0467
dos Santos, Wellington
Moody, Sarah https://orcid.org/0000-0003-4904-1041
Kazachkova, Mariya
Abbasi, Ammal
Steele, Christopher D.
Vangara, Raviteja https://orcid.org/0000-0001-5272-6207
Senkin, Sergey https://orcid.org/0000-0001-5848-005X
Wang, Jingwei https://orcid.org/0000-0002-0201-2369
Fitzgerald, Stephen https://orcid.org/0000-0003-0585-4833
Bergstrom, Erik N.
Khandekar, Azhar
Otlu, Burçak
Abedi-Ardekani, Behnoush
de Carvalho, Ana Carolina
Cattiaux, Thomas https://orcid.org/0000-0002-4826-7965
Penha, Ricardo Cortez Cardoso
Gaborieau, Valérie
Chopard, Priscilia
Carreira, Christine
Cheema, Saamin https://orcid.org/0000-0002-5297-2042
Latimer, Calli
Teague, Jon W.
Mukeriya, Anush
Zaridze, David
Cox, Riley
Albert, Monique
Phouthavongsy, Larry
Gallinger, Steven https://orcid.org/0000-0002-6998-9414
Malekzadeh, Reza
Niavarani, Ahmadreza https://orcid.org/0000-0001-7773-6778
Miladinov, Marko
Erić, Katarina
Milosavljevic, Sasa
Sangrajrang, Suleeporn
Curado, Maria Paula
Aguiar, Samuel
Reis, Rui Manuel https://orcid.org/0000-0002-9639-7940
Reis, Monise Tadin
Romagnolo, Luis Gustavo
Guimarães, Denise Peixoto
Holcatova, Ivana https://orcid.org/0000-0002-1366-0337
Kalvach, Jaroslav
Vaccaro, Carlos Alberto
Piñero, Tamara Alejandra
Świątkowska, Beata https://orcid.org/0000-0003-3757-3868
Lissowska, Jolanta
Roszkowska-Purska, Katarzyna
Huertas-Salgado, Antonio
Shibata, Tatsuhiro https://orcid.org/0000-0002-0477-210X
Shiba, Satoshi https://orcid.org/0000-0001-5159-5719
Sangkhathat, Surasak https://orcid.org/0000-0003-3622-3233
Chitapanarux, Taned
Roshandel, Gholamreza https://orcid.org/0000-0002-5494-0722
Ashton-Prolla, Patricia
Damin, Daniel C.
de Oliveira, Francine Hehn
Humphreys, Laura
Lawley, Trevor D. https://orcid.org/0000-0002-4805-621X
Perdomo, Sandra https://orcid.org/0000-0001-7740-8141
Stratton, Michael R. https://orcid.org/0000-0001-6035-153X
Brennan, Paul
Alexandrov, Ludmil B. https://orcid.org/0000-0003-3596-4515
Article History
Received: 25 August 2024
Accepted: 15 April 2025
First Online: 23 April 2025
Competing interests
: L.B.A. is a co-founder, chief scientific officer, scientific advisory member and consultant for, has equity in and receives income from io9. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. L.B.A. is also a compensated member of the scientific advisory board of Inocras. L.B.A.’s spouse is an employee of Hologic, Inc. E.N.B. is a consultant for, has equity in, and receives income from io9. A.A. and L.B.A. declare US provisional patent application filed with UCSD with serial number 63/366,392. E.N.B. and L.B.A. declare US provisional patent application filed with UCSD with serial number 63/269,033. L.B.A. also declares US provisional applications filed with UCSD with serial numbers 63/289,601 and 63/412,835, as well as international patent application PCT/US2023/010679. L.B.A. is also an inventor on US Patent 10,776,718 for source identification by non-negative matrix factorization. M.R.S. is founder, consultant, and stockholder for Quotient Therapeutics. L.B.A., M.D.-G., P.B., S.P., M.R.S. and S. Moody declare a European patent application with application number EP25305077.7. T.D.L. is a co-founder and CSO of Microbiotica. All other authors declare no competing interests.